Skip to main content
Inpatient Procedure Code

XW043S5

Introduction of Iobenguane I-131 Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5

Introduce Iobenguane I-131 in Central Vein, Perc, New Tech 5

Axis Breakdown

Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.

PositionValueMeaning
1
SectionX

New Technology

2
Body SystemW

Anatomical Regions

3
Root Operation0

Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4
Body Part4

Central Vein

5
Approach3

Percutaneous

6
Device / Substance / TechnologyS

Iobenguane I-131 Antineoplastic

7
New Technology Group5

New Technology Group 5

Related Codes

Same operation — other Body Part

Same table and root operation, differing only in the body part character.

XW033S5 — Introduction of Iobenguane I-131 Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 5

Same operation — other Device / Substance / Technology

Same table and root operation, differing only in the device / substance / technology character.

XW043E5 — Introduction of Remdesivir Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5, XW043F5 — Introduction of Other New Technology Therapeutic Substance into Central Vein, Percutaneous Approach, New Technology Group 5, XW043G5 — Introduction of Sarilumab into Central Vein, Percutaneous Approach, New Technology Group 5, XW043H5 — Introduction of Tocilizumab into Central Vein, Percutaneous Approach, New Technology Group 5, XW043Q5 — Introduction of Tagraxofusp-erzs Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5, XW043W5 — Introduction of Caplacizumab into Central Vein, Percutaneous Approach, New Technology Group 5

Contextual Map

Every relationship of XW043S5 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

  • XW0[PCS table]
  • [object Object] — Section: [object Object] [Section]: “[object Object]”
  • [object Object] — Body System: [object Object] [Body System]: “[object Object]”
  • [object Object] — Operation: [object Object] [Operation]: “[object Object]”

Nearest codes

  • XW033S5 — Introduction of Iobenguane I-131 Antineoplastic into Peripheral Vein, Percutaneous Approach, New Technology Group 5 [One axis away]
  • XW043E5 — Introduction of Remdesivir Anti-infective into Central Vein, Percutaneous Approach, New Technology Group 5 [One axis away]
  • XW043F5 — Introduction of Other New Technology Therapeutic Substance into Central Vein, Percutaneous Approach, New Technology Group 5 [One axis away]
  • XW043G5 — Introduction of Sarilumab into Central Vein, Percutaneous Approach, New Technology Group 5 [One axis away]
  • XW043H5 — Introduction of Tocilizumab into Central Vein, Percutaneous Approach, New Technology Group 5 [One axis away]
  • XW043Q5 — Introduction of Tagraxofusp-erzs Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5 [One axis away]
  • XW043W5 — Introduction of Caplacizumab into Central Vein, Percutaneous Approach, New Technology Group 5 [One axis away]

Change history

No changes recorded for this code — unchanged since the FY2026 (April) baseline of the change ledger.